Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential

European Journal of Nutrition

Volumn 53, Issue 7, 2014, Pages 1465-1474

  Panwar, Harsh ^a,b   Calderwood, Danielle ^a   Grant, Irene R ^a   Grover, Sunita ^b   Green, Brian D ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

Alpha glucosidase; Beta glucosidase; Lactobacillus

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; AMYLASE; ANTIDIABETIC AGENT; BACTERIAL EXTRACT; BETA GLUCOSIDASE INHIBITOR; GLUCOSE; GLYCOSIDASE INHIBITOR; LACTASE; SUCRASE; SUCROSE; UNCLASSIFIED DRUG; BACTERIAL DNA; BETA GLUCOSIDASE; ENZYME INHIBITOR; GLUCOSE BLOOD LEVEL; PROBIOTIC AGENT;

AMPLICON; ANTIDIABETIC ACTIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIFIDOBACTERIUM BIFIDUM; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; FECES; HUMAN; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; NONHUMAN; NUCLEOTIDE SEQUENCE; SALMONELLA TYPHIMURIUM; ANIMAL; ANTAGONISTS AND INHIBITORS; CLASSIFICATION; DIABETES MELLITUS, TYPE 2; ENZYMOLOGY; GLUCOSE BLOOD LEVEL; INFANT; INTESTINE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ACTINOPLANES SP.; ANIMALIA; BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM BIFIDUM; ESCHERICHIA COLI; LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; NEGIBACTERIA; POSIBACTERIA; RATTUS; SALMONELLA TYPHIMURIUM;

ACARBOSE; ALPHA-GLUCOSIDASES; AMYLASES; ANIMALS; BETA-GLUCOSIDASE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DNA, BACTERIAL; ENZYME INHIBITORS; FECES; GLYCOSIDE HYDROLASE INHIBITORS; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INTESTINES; LACTASE; LACTOBACILLUS; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; SEQUENCE ANALYSIS, DNA; SUCRASE;

EID: 84918799724     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-013-0649-9     Document Type: Article

References (37)

1. Sales PM, Souza PM, Simeoni LA, Magalhaes PO, Silveira D (2012) α-Amylase inhibitors: a review of raw material and isolated compounds from plant source. J Pharm Pharm Sci 15(1):141–183
2. Kazeem MI, Dansu TV, Adeola SA (2013) Inhibitory effect of Azadirachta indica A. Juss leaf extract on the activities of α-amylase and α-glucosidase. Pak J Biol Sci 16(21):1358–1362
3. Lebovitz HE (1997) Alpha-glucosidase inhibitors. Endocrinol Metab Clin 26(3):539–551
4. Derosa G, Maffioli P (2012) α-Glucosidase inhibitors and their use in clinical practice. Arch Med Sci 8(5):899–906
5. Creutzfeldt W (1999) Effects of the α-glucosidase inhibitor acarbose on the development of long term complications in diabetic animals: pathophysiological and therapeutic implications. Diabetes Metab Res Rev 15:289–296
6. Standl E, Schnell O (2012) Alpha-glucosidase inhibitors 2012—cardio vascular considerations and trial evaluation. Diabetes Vasc Dis Res 9(3):163–169
7. Chang J, Block TM, Guo JT (2013) Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions. Antivir Res 99(3):251–260
8. Rosak C, Mertes G (2012) Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations. Diabetes Metab Syndr Obes 5:357–367
9. Derosa G, Maffioli P (2012) Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review. Clin Ther 34(6):1221–1236
10. Tschope D, Hanefeld M, Meier JJ, Gitt AK, Halle M, Bramlage P, Schumm-Draeger PM (2013) The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes. Cardiovasc Diabetol 12:62
11. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072–2077
12. Al-Zuhair S, Dowaidar A, Kamal H (2010) Inhibitory effect of dates-extract on α-amylase and β-glucosidase enzymes relevant to non-insulin dependent diabetes mellitus. J Biochem Tech 2(2):158–160
13. Tundis R, Loizzo MR, Menichini F (2010) Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. Mini Rev Med Chem 10(4):315–331
14. Mohamed ELH, Siddiqui MJA, Ang LF, Sadikun A, Chan SH, Tan SC, Asmawi MZ, Yam MF (2012) Potent α-glucosidase and α-amylase inhibitory activities of standardized 50% ethanolic extracts and sinensetin from Orthosiphonstamineus Benth as anti-diabetic mechanism. BMC Complement Altern Med 12:176
15. Nair SS, Kavrekar V, Mishra A (2013) In vitro studies on alpha amylase and alpha glucosidase inhibitory activities of selected plant extracts. Eur J Exp Biol 3(1):128–132
16. Katekhaye SD, Nagmoti DM (2013) α-Glucosidase and α-amylase inhibitory activities of Pithecellobium dulce bark and leaves. Phytopharmacology 4(1):123–130
17. Yamada T, Hida H, Yamada Y (2007) Chemistry, physiological properties, and microbial production of hydroxycitric acid. Appl Microbiol Biotechnol 75(5):977–982
18. Schwientek P, Szczepanowski R, Ruckert C, Kalinowski J, Klein A, Selber K, Wehmeier UF, Stoye J, Puhler A (2012) The complete genome sequence of theacarbose producer Actinoplanes sp. SE50/110. BMC Genomics 13:112
19. Ramchandran L, Shah NP (2008) Proteolytic profiles and angiotensin-1 converting enzyme and alpha-glucosidase inhibitory activities of selected lactic acid bacteria. J Food Sci 73(2):M75–M81
20. Panwar H, Rashmi HM, Batish VK, Grover S (2013) Probiotics as potential biotherapeutics in the management of type 2 diabetes—prospects and perspectives. Diabetes Metab Res Rev 29:103–112
21. Ritchie ML, Romanuk TN (2012) A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 7(4):e34938
22. Chapman TM, Plosker GL, Figgitt DP (2007) Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseases. Bio Drugs 21(1):61–63
23. Anonymous or Sigma Tau Pharmaceuticals Inc. (2011) VSL#3 double strength product information sheet. http://www.vsl3.com/pdf/VSL3_DS_PL.pdf
24. Dubernet S, Desmasures N, Gueguen M (2002) A PCR based method for identification of lactobacilli at the genus level. FEMS Microbiol Lett 214(2):271–275
25. Turner S, Pryer KM, Miao VPW, Palmer JD (1999) Investigating deep phylogenetic relationships among cyanobacteria and plastids by small subunit rRNA sequence analysis. J Eukaryot Microbiol 46:327–338
26. Rogall TJ, Wolters TF, Bottger EC (1990) Towards a phylogeny and definition of species at the molecular level within the genus Mycobacterium. Int J Syst Bacteriol 40:323–330
27. Naser SM, Dawyndt P, Hoste B, Gevers D, Vandemeulebroecke K, Cleenwerck I, Vancanneyt M, Swings J (2007) Identification of lactobacilli by pheS and rpoA gene sequence analyses. Int J Syst Evol Microbiol 57:2777–2789
28. Burington RS (1973) Handbook of mathematical tables and formulas. McGraw-Hill, New York
29. Meng P, Xie C, Geng P, Qi X, Zheng F, Bai F (2013) Inhibitory effect of components from Streptomyces species on alpha-glucosidase and alpha-amylase of different origin. Prikl Biokhim Mikrobiol 49(2):181–189
30. Onose S, Ikeda R, Nakagawa K, Kimura T, Yamagishi K, Higuchi O, Miyazawa T (2013) Production of the α-glycosidase inhibitor 1-deoxynojirimycin from Bacillus species. Food Chem 138(1):516–523
31. Chaudet MM, Allen JL, Rose DR (2012) Expression and purification of two Family GH31 α-glucosidases from Bacteroides thetaiotaomicron. Protein Expr Purif 86(2):135–141
32. Ley RE, Peterson DA, Gordon JI (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124:837–848
33. Walter J, Ley R (2011) The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol 65:411–429
34. Mountzouris KC, Kotzampassi K, Tsirtsikos P, Kapoutzis K, Fegeros K (2009) Effects of Lactobacillus acidophilus on gut microflora metabolic biomarkers in fed and fasted rats. Clin Nutr 28(3):318–324
35. Perez-Martín F, Sesena S, Izquierdo PM, Martín R, Palop ML (2012) Screening for glycosidase activities of lactic acid bacteria as a biotechnological tool in oenology. World J Microbiol Biotechnol 28(4):1423–1432
36. Holt SM, Teresi JM, Cote GL (2008) Influence of alternansucrase-derived oligosaccharides and other carbohydrates on alpha-galactosidase and alpha-glucosidase activity in Bifidobacterium adolescentis. Lett Appl Microbiol 46(1):73–79
37. Park JE, Park SH, Woo JY, Hwang HS, Cha J, Lee H (2013) Enzymatic properties of a thermostable α-glucosidase from acidothermophilic crenarchaeon Sulfolobus tokodaii strain 7. J Microbiol Biotechnol 23(1):56–63